Position in ZTS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$195,530
+$194,524 QoQ
Shares Held
2,721
+33912.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,060
of 1,408 holders
Holding Since
Dec 2023
8 quarters on record
Voting authority
Sole 0%
Shared 1%
None 99%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Caitlin John, LLC holds $511,204 across 9 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (38.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
2,721 | $195,530 | |
| 2 | VTRS |
Viatris Inc
|
7,843 | $124,546 | |
| 3 | PCRX |
Pacira BioSciences, Inc.
|
4,721 | $119,771 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
68 | $36,844 | |
| 5 | PAHC |
Phibro Animal Health Corp
|
786 | $24,680 | |
| 6 | AQST |
Aquestive Therapeutics, Inc.
|
2,300 | $9,568 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
37 | $166 | |
| 8 | CRON |
Cronos Group Inc.
|
33 | $91 |
All Filings in ZTS
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $195,530 | 2,721 | Shares | Defined | 2026-08-17 | |
| 2025-12-31 | $1,006 | 8 | Shares | Defined | 2026-02-18 | |
| 2025-09-30 | $8,632 | 59 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $9,449 | 58 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $11,332 | 58 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,054 | 58 | Shares | Sole | 2025-01-27 | |
| 2024-03-31 | $28,765 | 170 | Shares | Sole | 2025-01-27 | |
| 2023-12-31 | $33,947 | 172 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||